CANRENONE - PRINCIPAL ACTIVE METABOLITE OF SPIRONOLACTONE

被引:35
作者
RAMSAY, LE [1 ]
SHELTON, JR [1 ]
WILKINSON, D [1 ]
TIDD, MJ [1 ]
机构
[1] GD SEARLE & CO LTD,DIV SCI AFFAIRS,HIGH WYCOMBE HP12 4HL,BUCKINGHAMSHIRE,ENGLAND
关键词
D O I
10.1111/j.1365-2125.1976.tb04883.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:607 / 612
页数:6
相关论文
共 20 条
[1]  
ARMITAGE P, 1971, STATISTICAL METHODS
[2]   INFUSION OF ALDOSTERONE, 9-ALPHA-FLUOROHYDROCORTISONE AND ANTIDIURETIC HORMONE INTO THE RENAL ARTERY OF NORMAL AND ADRENALECTOMIZED, UNANESTHETIZED DOGS - EFFECT ON ELECTROLYTE AND WATER EXCRETION [J].
BARGER, AC ;
BERLIN, RD ;
TULENKO, JF .
ENDOCRINOLOGY, 1958, 62 (06) :804-815
[3]   ALDOSTERONE BLOCKING EFFECTS OF SPIROLACTONES [J].
DRILL, VA .
JAPANESE JOURNAL OF PHARMACOLOGY, 1962, 11 (02) :77-&
[4]   MOLECULAR MODIFICATIONS OF ANTI-ALDOSTERONE COMPOUNDS - EFFECTS ON AFFINITY OF SPIRONOLACTONES FOR RENAL ALDOSTERONE RECEPTORS [J].
FUNDER, JW ;
FELDMAN, D ;
HIGHLAND, E ;
EDELMAN, IS .
BIOCHEMICAL PHARMACOLOGY, 1974, 23 (10) :1493-1501
[5]  
GOCHMAN N, 1962, J PHARMACOL EXP THER, V135, P312
[6]   FLUOROHYDROCORTISONEAND CHLOROHYDROCORTISONE, HIGHLY POTENT DERIVATIVES OF COMPOUND-F [J].
GOLDFIEN, A ;
LAIDLAW, JC ;
HAYDAR, NA ;
RENOLD, AE ;
THORN, GW .
NEW ENGLAND JOURNAL OF MEDICINE, 1955, 252 (11) :415-421
[7]  
HERMAN TS, 1968, J BIOL CHEM, V243, P3849
[9]  
KAGAWA CM, 1960, ENDOCRINOLOGY, V67, P125
[10]  
KAGAWA CM, 1964, P SOC EXP BIOL MED, V115, P837